Patent details

EP2841445 Title: 2.2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2841445
WO Application Number:
US2013038064
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP13720708.0
WO Publication Number:
WO2013163344
EPO Publication Language:
English
SPC Number:
301276
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
24/04/2013
Grant date:
14/06/2017
EP Publication Date:
04/03/2015
WO Publication Date:
31/10/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
25/08/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/06/2017
EP B1 Publication Date:
14/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
23/04/2033
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
07/05/2024
 
 

 

Name:
Reata Pharmaceuticals Holdings, LLC
Address:
5320 Legacy Drive, 75024, Plano, Texas, United States of America (US)

Historical Applicant/holder

From:
07/05/2024
To:
07/05/2024

 

Name:
Reata Pharmaceuticals, Inc.
Address:
2801 Gateway Drive, Suite 150, 75063, Irving, TX, United States of America (US)

From:
14/06/2017
To:
07/05/2024

 

Name:
Reata Pharmaceuticals, Inc.
Address:
2801 Gateway Drive, Suite 150, IRVING, TX 75063-2648, United States of America (US)

Domicile Holder

Name:
dr. W.A.H.M. Van Borm
From:
25/08/2017
Address:
DIPS Belgium bv Kernenergiestraat 19 bus P4, B-2610, Antwerpen (Wilrijk), Belgium (BE)
To:

Inventor

1

Name:
ANDERSON, Eric
Address:
Southlake, TX 76092, United States of America (US)

2

Name:
DECKER, Andrea
Address:
4055 Basel, Switzerland (CH)

3

Name:
LIU, Xiaofeng
Address:
Coppell, TX 75019, United States of America (US)

Priority

1

Priority Patent Number:
201361780444 P
Priority Date:
13/03/2013
Priority Country:
United States of America (US)

2

Priority Patent Number:
201361775288 P
Priority Date:
08/03/2013
Priority Country:
United States of America (US)

3

Priority Patent Number:
201261687669 P
Priority Date:
27/04/2012
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/565; A61P 29/00; C07J 63/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
21/24
Publication date:
22/05/2024
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
37/17
Publication date:
13/09/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
24/17
Publication date:
14/06/2017
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201729
Publication date:
19/07/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201724
Publication date:
14/06/2017
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202400870A
Date Registered:
07/05/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Novagraaf Technologies
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202400870C
Date Registered:
07/05/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Novagraaf Technologies
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Reata Pharmaceuticals Holdings, LLC
Address:
5320 Legacy Drive, 75024, Plano, Texas, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/04/2026
Annual Fee Number:
14
Annual Fee Amount:
800 Euro
Last Annual Payment Date:
19/03/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
700 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
08/09/2017 Outgoing Correspondence Letter no formal defects 1 PDF /5/8/3/6/6/0800166385/docs/ep13720708.0_2_160479l271.pdf
25/08/2017 Claims First filed claims 6 PDF /5/8/3/6/6/0800166385/docs/ep13720708.0_0_claims20170825233819043.pdf
25/08/2017 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /5/8/3/6/6/0800166385/docs/ep13720708.0_1_incomingcorrespondenceelectronic20170825233820374.pdf
25/08/2017 Incoming Correspondence Electronic Accompanying letter incoming document 1 PDF /5/8/3/6/6/0800166385/docs/ep13720708.0_3_incomingcorrespondenceelectronic20170825233817740.pdf